Epigenetic regulation of T cell lineages in skin and blood following hematopoietic stem cell transplantation.

Epigenetic regulation Hematopoietic stem cell transplantation Histone deacetylases T cells

Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
03 2023
Historique:
received: 31 08 2022
revised: 15 01 2023
accepted: 19 01 2023
pubmed: 27 1 2023
medline: 15 3 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Allogeneic hematopoietic stem-cell transplantation (HSCT) seeks to reconstitute the host's immune system from donor stem cells. The success of HSCT is threatened by complications including leukemia relapse or graft-versus-host-disease (GvHD). To investigate the underlying regulatory processes in central and peripheral T cell recovery, we performed sequential multi-omics analysis of T cells of the skin and blood during HSCT. We detected rapid effector T cell reconstitution, while emergence of regulatory T cells was delayed. Epigenetic and gene-regulatory programs were associated with recovering T cells and diverged greatly between skin and blood T cells. The BRG1/BRM-associated factor chromatin remodeling complex and histone deacetylases (HDACs) were epigenetic regulators involved in restoration of T cell homeostasis after transplantation. In isolated T cells of patients after HSCT, we observed class I HDAC-inhibitors to modulate their dysbalance. The present study highlights the importance of epigenetic regulation in the recovery of T cells following HSCT.

Identifiants

pubmed: 36702179
pii: S1521-6616(23)00024-4
doi: 10.1016/j.clim.2023.109245
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

109245

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that no conflict of interest exists.

Auteurs

Ram Vinay Pandey (RV)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria.

Johanna Strobl (J)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.

Anna Redl (A)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.

Luisa Unterluggauer (L)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria.

Laura Gail (L)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna 1090, Austria.

Lisa Kleissl (L)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna 1090, Austria.

Sophie Müller (S)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria.

Denise Atzmüller (D)

Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna 1090, Austria.

Victoria Fife-Gernedl (V)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria.

Thomas Krausgruber (T)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Hanna Knaus (H)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Vienna 1090, Austria.

Margit Mitterbauer (M)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Vienna 1090, Austria.

Philipp Wohlfarth (P)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Vienna 1090, Austria.

Werner Rabitsch (W)

Department of Internal Medicine I, Bone Marrow Transplantation Unit, Medical University of Vienna, Vienna 1090, Austria.

Christoph Bock (C)

CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna 1090, Austria; Institute of Artificial Intelligence, Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria.

Georg Stary (G)

Department of Dermatology, Medical University of Vienna, Vienna 1090, Austria; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna 1090, Austria; Ludwig Boltzmann Institute for Rare and Undiagnosed Diseases, Vienna 1090, Austria. Electronic address: georg.stary@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH